Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 33 for “"brain targeting"”.
-
Novel gene delivery systems for brain targeting
Disorders of the central nervous system such as brain tumours, Alzheimer's disease, Parkinson's disease, Huntington's disease and others lead to a worst decline in the quality of life of patients. The possibility of using gene therapy for the treatment of these disorders is hindered due to the …
-
Development Of A Liposomal Formulation For Brain Targeting
The blood-brain barrier (BBB), formed by the endothelial cells of the brain capillaries, inhibits the penetration of many therapeutic compounds into the brain. Liposomes, which have unique physicochemical characteristics, have been widely investigated for the drug delivery system across BBB. In the …
-
Design, Synthesis, and Evaluation of Glutathione Derivatives as Brain Targeting Agents
… Alzheimer’s disease, Parkinson’s diseases, and brain tumors, is still a challenge due to the existence of the blood-brain barrier (BBB). The BBB as a membrane barrier that separates systemic blood circulation from the CNS is structurally formed by endothelial cells, astrocyte, pericyte and …
-
Design, Synthesis, and Evaluation of GUNW-3 as a Brain Targeting Agent
The blood brain barrier (BBB) is a barrier in the brain that separates the peripheral blood circulation system from the central nerve system (CNS). The barrier effectively protects the brain from xenobiotics. The BBB serves as a physical barrier through the tight junction of endothelial cells that …
-
Development of liposomal formulations for mucosal vaccination and brain targeting via the nasal route
… as a reconstitutable product designed for brain-targeted delivery via intranasal administration. The liposomal composition in this formulation was based on the previous work and comprised: soy phosphatidylcholine (SPC), D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) and …
-
A smart approach for brain targeting of mesenchymal stem cells secretome in Parkinson’s disease
… major objective of this thesis was to developed brain-targeting functionalized lipidbased nanoparticles to function as delivery vehicles for secretome. Firstly, we aimed to assess the effect of aging in a 6-hydroxydopamine-induced PD rodent model, which is widely used on research. The rationale …
-
Ανάπτυξη καινοτόμων νανομορφών για στοχευμένη μεταφορά θεραπευτικών ή/και απεικονιστικών ουσιών στον εγκέφαλο
… of therapeutic and imaging substances to the brain is impossible due to the existence of the blood-brain barrier (BBB). The application of nanotechnology to face this problem has recently begun to show signs of success. Because of the difficulties in neurodegenerative diseases therapeutics and …
-
Understanding the effects of isoDGR in neurodegeneration
… investigated the effects of isoDGR-motif on key brain cell types, including brain endothelial cells (bEnd3) and neurons (N2A) using in vitro models. IsoDGR exposure induced cellular senescence, characterized by increased β-galactosidase activity, elevated p16 and p53 expression, nuclear …
-
CHITOSAN AND ITS DERIVATIVE NANOPARTICLES FOR DRUG DELIVERY INTO BRAIN USING INTRANASAL ADMINISTRATION: PREPARATION, CHARACTERIZATION, IN VITRO AND IN VIVO EVALUATION
The presence of blood-brain barrier restricts the entry of most drugs for the treatment of central nervous system diseases. To overcome this problem and enhance the drug permeability into brain, we propose using carboxymethyl chitosan and chitosan nanoparticles as carriers to deliver drugs …
-
Dual-Functionalized Liposomes for Gene Delivery to Brain to Prevent and Treat Alzheimer’s Disease
… (NGF) by transporting pDNA across the blood brain barrier (BBB) and expressing the ApoE2 or NGF into brain, using brain-targeted liposomal nanoparticles for treatment of AD. We explored the neuroprotective functions of ApoE2 and survival-promoting properties of NGF through gene therapy as …
-
Supramolecular Structure-Enabled Delivery of Porphyrin to Glioblastomas Beyond the Blood-Brain Barrier
… surgery (FGS) are two promising modalities for targeting glioblastoma infiltrates and overcoming therapy resistance. However, the presence of an intact blood-brain barrier (BBB) within infiltrative tumor tissue restricts porphyrin delivery and, thereby, therapeutic efficacy. This thesis …
-
Brain Invaders: IgG and IgG receptors in schizophrenia
… proinflammatory cytokines are found in the brain and the blood from schizophrenia cases and are used to define the “high” and “low” inflammatory biotypes. Cytokines elevated in schizophrenia mediate IgG release and effector functions. Yet, whether IgG, its transporter (FcGRT), …
-
Effects of psychotropic drugs on the microbiota-gut-liver-brain axis
… turning). With few isolated studies showing that brain-targeting medications can have antimicrobial activity in vitro, we sought to investigate the impact of psychotropics on the microbiome and intestinal physiology in vivo. Across a range of psychotropic medications, lithium, valproate, …
-
A Transferrin conjugated nanoemulsion system for brain delivery of antiretroviral therapy
… because they cannot efficiently cross the blood-brain barrier (BBB). The goal of this study is to develop a new transferrin conjugated nanoemulsion system (Tf-NE) for antiretroviral medication delivery and evaluate its potential to cross the BBB. Nanoemulsions were prepared based on the solvent …
-
Development of implantable devices for schizophrenia treatment
… by abnormal levels of neurotransmitters in the brain. One of the drugs that is commonly prescribed to treat schizophrenia is risperidone (RIS). This drug is administered through the oral route (e.g. tablets). Accordingly, the drug is exposed to first-pass metabolism and enzymatic degradation in …
-
Qualitative and quantitative analysis of glycans released from model glycoproteins and pooled human blood serum using MRM Mode and ESI LC-MS/MS
… the N-glycans differentially expressed in brain-targeting breast carcinoma cells (MDA-MB-231-Br) and was compared with MDA-MB-231 breast cancer cell line. Thus, MRM measurements provide a rapid and reliable identification and quantification of glycans that could be applied in biomarker …
-
A novel vascular targeting strategy to the blood brain barrier using a TCR mimic antibody
The blood-brain barrier (BBB) plays a crucial role in treatment of CNS diseases, because it restricts the diffusion of large or hydrophilic molecules into the brain. Therefore, targeting transport mechanisms on endothelial cells of the brain microvasculature could lead to improved diagnostic and …
-
NOVEL ENZYME-RESPONSIVE SELF ASSEMBLED PEPTIDE NANOCARRIERS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
… and adapted to achieve drug penetration into the brain, evolving alongside our understanding of the physiological barriers between the brain and surrounding tissues. The blood brain barrier (BBB) has been described as the major barrier for drug delivery to the brain (1). In this project, novel …
-
Monocarboxylate Transporters in gliomas: regulation and therapeutic implications
Glioblastoma (GBMs) is the brain tumour with the highest prevalence and lethality. Besides the progress in therapy, the overall survival is still 15 months and patients have a worse prognosis. Thus, it is important to identify new molecular therapeutic targets that could improve the quality of life …
-
Nose to Brain Delivery of Therapeutic Agents
… and do not allow frequent administration. Brain targeting of drugs by intranasal route is a safe and noninvasive method of drug delivery which allows frequent administration and is certainly more patient compliant than the currently folloinvasive methods. In this study, the plausibility of …
Page 1 of 2